Does the Market Choose Optimal Health Insurance Coverage

Research output: Working paperDiscussion paperOther research output

341 Downloads (Pure)

Abstract

Abstract Consumers, when buying health insurance, do not know the exact value of each treatment that they buy coverage for. This leads them to overvalue some treatments and undervalue others. We show that the insurance market cannot correct these mistakes. This causes research labs to overinvest in treatments that hardly add value compared to current best practice. The government can stimulate R&D in breakthrough treatments by excluding treatments with low value added from health insurance coverage. If the country is rich enough such a government intervention in a private health insurance market raises welfare.
Original languageEnglish
Place of PublicationTilburg
PublisherTILEC
Number of pages40
Volume2013-008
Publication statusPublished - 2013

Publication series

NameTILEC Discussion Paper
Volume2013-008

Keywords

  • cost effectiveness analysis
  • pharmaceutical research and development
  • health insurance

Fingerprint Dive into the research topics of 'Does the Market Choose Optimal Health Insurance Coverage'. Together they form a unique fingerprint.

  • Cite this

    Boone, J. (2013). Does the Market Choose Optimal Health Insurance Coverage. (TILEC Discussion Paper; Vol. 2013-008). TILEC.